These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11100309)

  • 21. The cost of a successful delivery with in vitro fertilization.
    Neumann PJ; Gharib SD; Weinstein MC
    N Engl J Med; 1994 Jul; 331(4):239-43. PubMed ID: 8015571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Funding in vitro fertilization treatment for persistent subfertility: the pain and the politics.
    Hughes EG; Giacomini M
    Fertil Steril; 2001 Sep; 76(3):431-42. PubMed ID: 11532460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indications for assisted conception.
    Hull MG
    Br Med Bull; 1990 Jul; 46(3):580-95. PubMed ID: 2207595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic implications of insurance coverage for in vitro fertilization in the United States. A review.
    Omurtag KR; Styer AK; Session D; Toth TL
    J Reprod Med; 2009; 54(11-12):661-8. PubMed ID: 20120898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015.
    Dieke AC; Mehta A; Kissin DM; Nangia AK; Warner L; Boulet SL
    Fertil Steril; 2018 Apr; 109(4):691-697. PubMed ID: 29580644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical review 87: In vitro fertilization for male factor infertility.
    Schlegel PN; Girardi SK
    J Clin Endocrinol Metab; 1997 Mar; 82(3):709-16. PubMed ID: 9062469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diversity of regulation and public financing of IVF in Europe and its impact on utilization.
    Berg Brigham K; Cadier B; Chevreul K
    Hum Reprod; 2013 Mar; 28(3):666-75. PubMed ID: 23223400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of infertility treatments: choice and comparative analysis.
    Hull MG
    Int J Gynaecol Obstet; 1994 Nov; 47(2):99-108. PubMed ID: 7843496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intrauterine insemination: state-of-the-art in humans].
    Royère D
    Gynecol Obstet Fertil; 2004 Oct; 32(10):873-9. PubMed ID: 15501166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-based approach to unexplained infertility: a systematic review.
    Gunn DD; Bates GW
    Fertil Steril; 2016 Jun; 105(6):1566-1574.e1. PubMed ID: 26902860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcomes after assisted human reproduction.
    Okun N; Sierra S; ;
    J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In-vitro fertilization in economic perspective].
    Haan G; van Steen RH
    Ned Tijdschr Geneeskd; 1990 Oct; 134(43):2098-102. PubMed ID: 2122265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria.
    Busnelli A; Papaleo E; Del Prato D; La Vecchia I; Iachini E; Paffoni A; Candiani M; Somigliana E
    Hum Reprod; 2015 Feb; 30(2):315-22. PubMed ID: 25432927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seeking coverage for infertility. Insurers should offer reasonable services to help couples achieve pregnancy.
    Angard NT
    AWHONN Lifelines; 2000; 4(3):22-4. PubMed ID: 11249385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of a Swedish infertile cohort 2005-08: population characteristics, treatments and pregnancy rates.
    Aanesen A; Westerbotn M
    Fam Pract; 2014 Jun; 31(3):290-7. PubMed ID: 24591683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of microscopic epididymal sperm aspiration and intracytoplasmic sperm injection/in-vitro fertilization with repeat microscopic reconstruction following vasectomy: is second attempt vas reversal worth the effort?
    Donovan JF; DiBaise M; Sparks AE; Kessler J; Sandlow JI
    Hum Reprod; 1998 Feb; 13(2):387-93. PubMed ID: 9557844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-benefit Analysis of IUI and IVF based on willingness to pay approach; case study: Iran.
    Darvishi A; Goudarzi R; Zadeh VH; Barouni M
    PLoS One; 2020; 15(7):e0231584. PubMed ID: 32663214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of treatment for unexplained infertility.
    Guzick DS; Sullivan MW; Adamson GD; Cedars MI; Falk RJ; Peterson EP; Steinkampf MP
    Fertil Steril; 1998 Aug; 70(2):207-13. PubMed ID: 9696208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of assisted conception for male subfertility.
    Moolenaar LM; Cissen M; de Bruin JP; Hompes PG; Repping S; van der Veen F; Mol BW
    Reprod Biomed Online; 2015 Jun; 30(6):659-66. PubMed ID: 25900905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro fertilization (IVF) versus gonadotropins followed by IVF as treatment for primary infertility: a cost-based decision analysis.
    Kansal-Kalra S; Milad MP; Grobman WA
    Fertil Steril; 2005 Sep; 84(3):600-4. PubMed ID: 16169391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.